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Oxidative protein folding in Gram-negative bacteria
results in the formation of disulfide bonds between pairs of
cysteine residues. This is a multistep process in which the
dithiol-disulfide oxidoreductase enzyme, DsbA, plays a cen-
tral role. The structure of DsbA comprises an all helical
domain of unknown function and a thioredoxin domain,
where active site cysteines shuttle between an oxidized, sub-
strate-bound, reduced form and a DsbB-bound form, where
DsbB is a membrane protein that reoxidizes DsbA. Most
DsbA enzymes interact with a wide variety of reduced sub-
strates and show little specificity. However, a number of
DsbA enzymes have now been identified that have narrow
substrate repertoires and appear to interact specifically with
a smaller number of substrates. The transient nature of the
DsbA-substrate complex has hampered our understanding of
the factors that govern the interaction of DsbA enzymes with
their substrates. Here we report the crystal structure of a
complex between Escherichia coli DsbA and a peptide with a
sequence derived from a substrate. The binding site identi-
fied in the DsbA-peptide complex was distinct from that
observed for DsbB in the DsbA-DsbB complex. The structure
revealed details of the DsbA-peptide interaction and sug-
gested a mechanism by which DsbA can simultaneously show
broad specificity for substrates yet exhibit specificity for
DsbB. This mode of binding was supported by solution
nuclear magnetic resonance data as well as functional data,
which demonstrated that the substrate specificity of DsbA
could be modified via changes at the binding interface iden-
tified in the structure of the complex.
The formation of disulfide bonds is a critical step in the cor-
rect folding and stability of many secreted proteins. In Gram-
negative bacteria, disulfide bond formation occurs in the
periplasm and is catalyzed by enzymes of the Dsb family. The
Dsb family contains several members, which mediate different
aspects of disulfide bond formation and isomerization (1).
DsbA is the enzyme that is primarily responsible for the forma-
tion of disulfide bonds in newly synthesized substrate proteins
(Fig. 1). In this reaction, oxidized DsbA reacts with a substrate
protein to generate a mixed disulfide intermediate. This cova-
lent reaction intermediate is rapidly resolved to release the oxi-
dized substrate and reduced DsbA. Reduced DsbA is in turn
reoxidized by the inner membrane protein DsbB (2).
Bacteria lacking a functional DsbA display pleiotropic phe-
notypes, since the folding of a large number of disulfide bond-
containing proteins is disrupted. Many of these are secreted
proteins, such as toxins and surface proteins, that contribute to
bacterial virulence (3). For example, DsbA is required for the
formation of a functional type III secretion system in many
bacteria, including Pseudomonas aeruginosa (4, 5), Shigella
flexneri (6), Salmonella enterica serovar Typhimurium (7), and
Yersinia pestis (8); dsbA Vibrio cholerae are unable to secrete
cholera toxin (9); dsbA strains of E. coli exhibit reduced levels
of -lactamase activity (10) and are hypersensitive to benzyl
penicillin, dithiothreitol (11), and some divalent metal cations
(12). Furthermore, DsbA has been shown to be necessary for
intracellular survival of S. flexneri (13) and P. aeruginosa (4),
and DsbA is required for virulence of S. enterica in a mouse
infection model (7). Each of these phenotypes has been attrib-
uted to the lack of disulfide formation in protein substrates of
DsbA. Thus, there has been considerable interest in the struc-
tural basis of DsbA activity and selectivity and its role in bacte-
rial virulence.
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The structures of DsbA from E. coli (EcDsbA) and V. chol-
erae (VcDsbA) have been solved in both their reduced and oxi-
dized forms (14–18). Each contains a thioredoxin (TRX)5
domain, a common structural fold of thiol-disulfide oxi-
doreductases (19), and an inserted helical domain (14). DsbA
enzymes contain a single pair of redox-active cysteines in a
CXXC motif (Cys30-Pro31-His32-Cys33 in EcDsbA) and a cis-
proline residue (Pro151 in EcDsbA) that is adjacent in the three-
dimensional fold but distant in the sequence; both are con-
served features of the redox-active TRX fold (19). EcDsbA and
VcDsbA share relatively low sequence similarity (40%), yet
retain conserved surface features around their active sites,
which have been proposed to form the substrate-binding site
(20). These include a hydrophobic patch and a hydrophobic
groove, which flank the active site of the enzyme. Within the
hydrophobic groove is the cis-proline residue that is a con-
served feature of the TRX fold and in DsbA is found in a loop at
the end of a long helix, which links the -helical and TRX
domains. The structure of EcDsbA has been determined in
complexwithDsbB (21), which revealed that a periplasmic loop
of DsbB is bound within the hydrophobic groove of DsbA (21).
The hydrophobic groove has also been widely assumed to be
the substrate-binding site of DsbA, although the transient
nature of DsbA-substrate complexes has hindered their struc-
tural characterization.
Many DsbA enzymes display broad substrate specificity. In
E. coli, for example, it has been estimated that DsbA may oxi-
dize hundreds of different substrate proteins (22). More
recently, a number of DsbA enzymes have been described that
display narrower substrate specificity, and the structures of sev-
eral of these have been reported. These include a DsbA enzyme
from Neisseria meningitidis (NmDsbA3) (23) as well as DsbA
from the Gram-positive organism Staphylococcus aureus
(SaDsbA) (24) and a second DsbA enzyme (DsbL) (25) that is
present in some uropathogenic strains of E. coli (25). Func-
tional characterization has revealed that both SaDsbA and
NmDsbA3 can only partially complement dsbA E. coli (24,
26), suggesting that both have a narrower substrate repertoire
than EcDsbA, whereas biochemical analysis has revealed that
NmDsbA3 is a substrate for EcDsbB (23) and that SaDsbA is not
(24). DsbLhas been shown to partially restoremotility todsbA
E. coli in a DsbA complementation assay, but biochemical anal-
ysis revealed that it does not show DsbA-like activity in stand-
ard oxidoreductase assays, such as RNase refolding and insulin
reduction (25).
Despite their functional differences, all of the characterized
DsbA enzymes share a similar tertiary structure, and minimal
changes have been observed between the reported structures of
reduced and oxidized forms of the protein. There are, however,
some differences in the sequences around the active sites that
may contribute to the observed differences in activity between
these DsbA enzymes. For example, in most DsbA enzymes,
there is a valine residue preceding the conserved cis-proline
(VcP). In both SaDsbA and NmDsbA3, the residue preceding
the cis-proline is a threonine (TcP). The TcPmotif is also found
in Gram-negative disulfide isomerase proteins (DsbC and
DsbG). It has previously been demonstrated that mutations in
the cis-proline loop of DsbC and DsbG can affect the substrate
specificity of these enzymes (27), andmore recently, it has been
demonstrated that this residue is important in dictating the
function ofmany TRX fold proteins (28). AlthoughDsbLmain-
tains the VcP sequence, structures have revealed that SaDsbA
and DsbL lack the hydrophobic surface features surrounding
their active sites, whereas NmDsbA3 presents a similar hydro-
phobic surface around the active site but adopts a different
conformation in the loops linking the two domains, which are
adjacent to the active site.
These findings suggest that there are subtle differences in the
processes that mediate recognition of substrates by oxidized
DsbA and recognition of DsbB by reduced DsbA. This observa-
tion is supported by analysis of N. meningitidis, which express
three chromosomally encoded DsbA enzymes (29, 30). Two of
these Neisserial DsbA enzymes (NmDsbA1 and NmDsbA2)
share 73% sequence identity (29) and maintain the canonical
DsbA active site sequence (Cys-Pro-His-Cys). However,
complementation of dsbA E. coli with NmDsbA1 or
NmDsbA2 produced transformants with different phenotypes
(29), suggesting that these enzymes are capable of discriminat-
ing between specific substrates (29, 30). However, both
NmDsbA1 and NmDsbA2 were shown to complement the
DTT sensitivity of dsbA E. coli, suggesting that although they
differ in their specificity for oxidizing substrate proteins (29),
both are functional oxidoreductases, and are capable of being
reoxidized by EcDsbB.
Structural details of howDsbA recognizes its substrates have
proved difficult to obtain, since the covalent reaction interme-
diates between DsbA and its substrates are relatively short
lived. Although amutant DsbA protein has been identified that
stabilizes the mixed disulfide intermediates (31), there are cur-
5 The abbreviations used are: TRX, thioredoxin; Trt, triphenylmethyl; cP, cis-
proline; DTT, dithiothreitol; HPLC, high pressure liquid chromatography;
Hse, homoserine residue; r.m.s., root mean square.
FIGURE 1. The catalytic cycle of DsbA. a, oxidized DsbA reacts with a variety
of substrate proteins to generate a mixed disulfide DsbA-substrate complex
(b). The complex is rapidly resolved with release of oxidized substrate and
reduced DsbA (c). Reduced DsbA reacts specifically with membrane-bound
DsbB to formamixeddisulfideDsbA-DsbB complex (d), which results in reoxi-
dation of DsbA and reduction of DsbB.
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rently no structural details of any DsbA-substrate complex.
Herein we report the structure of a covalent DsbA-peptide
complex refined to a resolution of 1.9 Å. It has previously been
found that reduced peptides and proteins are oxidized with
similar kinetics (32–34), suggesting that peptides are suitable
models of the reduced unfolded proteins that are the substrates
of DsbA. Our structure reveals that the peptide binds to DsbA
at a surface formed by residues at the interface between the
-helical and TRX domains and not within the hydrophobic
groove that is the binding site for DsbB. Phenotypic assays were
undertaken using chimeric proteins containing the -domains
of Neisserial DsbA enzymes grafted into the TRX domain of
EcDsbA that introduce mutations at the domain interface and
cis-proline loop that form the peptide binding site while main-
taining the hydrophobic groove that is the binding site of DsbB.
These revealed that the chimeras were functional oxidoreduc-
tase enzymes but that the phenotypes observed in the assays
were modulated by changes at the peptide binding site identi-
fied in our structures of the complex. Taken together, these
data suggest that the interface formed between the TRX and
-helical domains of DsbA is an important determinant of
specificity in the reaction between oxidized DsbA and its sub-
strates and that DsbA activitymay bemodulated throughmod-
ifications to the nature of this surface and changes in the cis-
proline loop.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification—Standard molecular
biology techniques were utilized throughout. The gene encod-
ing EcDsbA was cloned into the expression vector pTrc99A
(35), which was used to transform E. coli BL21 DE3 Codon Plus
cells (Stratagene). Bacterial cultures were grown at 37 °C until
A600 reached 0.6, when expression was induced with the addi-
tion of isopropyl 1-thio--D-galactopyranoside (1 mM), and the
cultures were grown for a further 5 h. Periplasmic extracts were
obtained by resuspending the cell pellet in 20 mM Tris, pH 8.0,
150 mM NaCl containing polymyxin B sulfate (1 mg ml1) for
2 h at 4 °C. DsbA was purified as described previously, reduced
with Tris(2-carboxyethyl)phosphine-HCl at a 1:10 molar ratio,
buffer-exchanged into 10 mM HEPES (pH 7.8), 0.1 mM EDTA,
and concentrated to 20 mg ml1 for crystallization. Uniformly
15N and 13C/15N isotope-labeled protein was produced accord-
ing to themethod ofMarley et al. (36) and purified as described
above. Samples forNMR contained uniformly 13C/15N EcDsbA
(300 M in 20 mM HEPES, pH 7.0, 150 mM NaCl, 10% D2O).
Homogeneity of the purified proteins was assessed by SDS-
PAGE (silver staining) and by electrospray ionization mass
spectrometry on a Micromass Platform II liquid chromatogra-
phy/quadrupole mass spectrometry system (Manchester, UK).
Protein concentration was determined by UV-visible spectro-
photometry using a molar extinction coefficient at 280 nm of
23,045 cm1 M1.
Kinetics of Disulfide Oxidation—Disulfide oxidase activity
was measured by following the change in the intrinsic fluores-
cence of EcDsbA upon oxidation of a peptide derived from the
mature sequence of the S. flexneri autotransporter protein
SigA. Synthesis of the N-terminally acetylated sequence, Ac-G-
N(Trt)-N(Trt)-N(Trt)-C(Trt)-P-I-P-F-L-C(Trt)-Q(Trt)-K(t-
butoxycarbonyl)-D(t-butoxy)-RESIN was performed on Rink
Resin under standard solid phase peptide synthesis conditions.
Cleavage and deprotection was carried out using 95% trifluoro-
acetic acid fromwhich the peptidewas recovered using a stand-
ard sequence of ether precipitation, dissolution in 50% aqueous
acetonitrile, and freeze drying. The product was subjected to
semipreparative HPLC purification, allowing the isolation of
the peptide in high purity (m/z 1604.5 MH). The kinetics of
oxidation of the SigA peptide by EcDsbA was determined in
phosphate-buffered saline (pH 7.2), using an Applied Photo-
physics SF.18MV stopped-flow apparatus, thermostatted at
30 °C. Peptide oxidation was followed by monitoring the
change in intrinsic fluorescence of EcDsbA upon reduction at
wavelengths of 320 nm (ex  295 nm). Oxidation reaction
mixtures contained EcDbsA (1–10 M) to which the SigA pep-
tide was added over a range of concentrations (1–25 M). The
initial rates of the oxidation reactions were determined from
the linear portion of the fluorescence data, and these were used
to determine the apparent second order rate constant for the
reaction as described previously (34).
Peptide Synthesis—Synthesis of the N-terminally acetylated
sequence from SigA, Ac-P-I-P-F-L-Hse(Trt)-Q(Trt)-K(t-bu-
toxycarbonyl)-D(t-butoxy)-RESIN, was performed on Rink
Resin under standard solid phase peptide synthesis conditions.
The peptide was cleaved and deprotected with 95% trifluoro-
acetic acid recovered as described above and purified using
semipreparative HPLC, yielding the peptide in high purity (m/z
1100 MH). The strategy for formation of the covalent com-
plex followed to a large extent themethod described byCouprie
et al. (37). For synthesis of the bromopeptide, the homoserine
sequence was assembled on resin as above, trityl protecting
groups were removed by five cycles of treatment with 1:5:94
trifluoroacetic acid/triisopropylsilane/dichloromethane, and
the exposed alcohol was brominated by extended treatment
with CBr4/Ph3P in tetrahydrofuran. After extensive washing,
final cleavage and deprotection was carried out using 95% tri-
fluoroacetic acid. The brominated product was efficiently
recovered after trifluoroacetic acid cleavage by ether precipita-
tion, dissolution in 50% aqueous acetonitrile, and freeze drying.
The product was stable to semipreparative HPLC purification,
allowing the isolation of the peptide in high purity (m/z 1162
MH) and good yield (20 mg). The homoserine-containing
peptide (m/z 1100 MH) was a minor component from the
cleavage reaction. The bromopeptides were found to be stable
to storage and not readily hydrolyzed under the aqueous con-
ditions of complex formation with the protein.
Crystallization—Crystals of reduced EcDsbA were grown at
4 °C using the hanging drop technique. Crystals grew within 3
days from equal volumes of protein solution and a reservoir
solution containing 0.2 M ammonium acetate, 20% (w/v) poly-
ethlylene glycol 4000, and 0.1 M sodium citrate (pH 5.8). Crys-
tals were soaked overnight at 4 °C in solution containing 0.2 M
ammonium acetate, 28% (w/v) polyethlylene glycol 4000, 10%
(v/v) glycerol, and 0.1 M sodium citrate (pH 5.8) supplemented
with 3.5 mM bromopeptide, 3.5 mM Tris(2-carboxyethyl)phos-
phine-HCl, and 0.1mMEDTA. Soaked crystals were then trans-
ferred into a cryoprotectant solution containing 0.2 M ammo-
nium acetate, 28% (w/v) polyethlylene glycol 4000, 10% (v/v)
The Structure of a DsbA-Peptide Complex
JUNE 26, 2009•VOLUME 284•NUMBER 26 JOURNAL OF BIOLOGICAL CHEMISTRY 17837
 at UQ Library on September 1, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
glycerol, and 0.1 M sodium citrate (pH 5.8) and flash-frozen
prior to data collection.
Structure Determination and Refinement—Data were col-
lected at the Advanced Photo Source (Argonne National Labo-
ratory, Argonne, IL) on beamline IMCA-CAT-17-ID-B at 100
K and were processed and scaled using the HKL suite. The
crystals belong to space group P212121, and the unit cell dimen-
sions were consistent with 4 molecules/asymmetric unit (see
Table 1). The structure of DsbA in complex with the SigA pep-
tide was determined by molecular replacement using a previ-
ously determined structure of reduced DsbA (Protein Data
Bank accession code 1a2l) as the search model. The model was
built manually using the program O and refined to 1.9 Å reso-
lution using the CCP4 program suite (38). Each of the four
DsbA molecules was built independently, and no NCS
restraints were used during the refinement. The quality of the
modelwas determined bymonitoring theRwork andRfree values.
In the finalmodel 93.6% of residues were foundwithin themost
favored regions of the Ramachandran plot, with the remaining
6.4% in the allowed regions. Statistics for the final structures are
summarized in Table 1.
NMRSpectroscopy—NMRexperimentswere carried out on a
Varian Unity 600-MHz spectrometer equipped with a single
axis gradient triple resonance cryoprobe. Standard triple reso-
nance experiments were employed to confirm the published
assignments for EcDsbA (16). Data were processed using
NMRPipe (39) and were analyzed using the program SPARKY.
Overall weighted average chemical shift changes (avg) were
calculated for all residues, using the equation (40),
avg H
2 0.154 N
20.5 (Eq. 1)
where H and N denote the changes in chemical shift for amide
proton and nitrogen resonances, respectively, upon the addi-
tion of the SigA homoserine-containing peptide (Ac-PIPFL-
Hse-QKD-NH2) (1 mM). The assigned 1H and 15N resonances
for the apo- and peptide-complex of EcDsbA are presented in
supplemental Table 1. Residues that underwent the greatest
changes in chemical shift were mapped onto the crystal
structure of the complex to identify the binding location of
the peptide.
Construction of Chimeric DsbA Proteins—Chimeric dsbA
genes were created that contained the EcDsbA TRX domain
and theNmDsbA1orNmDsbA2-domains. Thiswas achieved
through three-way splice overlap extension PCR (41). Each of
the domains was amplified in the first round of PCRwith prim-
ers having 6-bp overhangs of sequence complementary to the
adjacent fragment to which it was to anneal. The second round
of PCR allowed the 12-bp overlaps to anneal to form the chi-
meric dsbA gene template that was then amplified. Expression
plasmidswere constructed by cloning the appropriate gene into
the expression plasmid pTrc99A (35).
Complementation of dsbA E. coli—The E. coli JCB strains
were kindly provided by J. C. Bardwell (Harvard Medical
School) (10), and transformations of E. coli strain JCB571 were
performed chemically (42). Transformants were selected on LB
agar containing appropriate antibiotics and confirmed by col-
ony PCR.
Phenotypic Assays—Oxidoreductase activity assays were
undertaken for each expression construct by testing the DTT
sensitivity of transformed cells (43). Bacteria were grown in LB
to midlog phase when the cell density was determined spectro-
photometrically, and the cultures were standardized to a con-
centration of 2 	 108 cells/ml. 10-Fold serial dilutions were
prepared, and an aliquot (5 l) of each concentration was
deposited onto LB-agar plates with and without DTT (15 mM).
After drying, the plates were incubated at 37 °C for 18 h.
Motility assays were performed essentially as described (44)
on soft LB-agar (0.4%). Bacteria were grown in LB to midlog
phase when the cell density was determined spectrophoto-
metrically, and the cultures were standardized to a concentra-
tion of 2 	 108 cells/ml. Samples (5 l) were drop-inoculated
onto the soft agar and incubated at 37 °C overnight to allow
swarming.
Conscore—A simple conservation scheme (45) was used to
calculate amino acid conservation in confirmed DsbA sub-
strates. The substrates used in the analysis are listed in supple-
mental Table 2. Five residues on either side of cysteine residues
in known substrates of EcDsbAwere investigated. Conservative
substitution was defined as belonging to one of the following
seven groups: 1) hydrophobic (alanine, valine, leucine, and iso-
leucine), 2) aromatic hydrophobic (tryptophan, tyrosine, and
phenylalanine), 3) basic (arginine, histidine, and lysine), 4)
acidic (glutamic acid and aspartic acid), 5) neutral polar (serine,
methionine, threonine, cysteine, asparagine, and glutamine), 6)
glycine, and 7) proline. 45 cysteine-containing sequences from
proteins that have been shown to be substrates of EcDsbAwere
analyzed to determine the degree of conservation in residues
surrounding the cysteine.
RESULTS
Disulfide Oxidase Activity—Disulfide oxidase activity was
determined in vitro by measuring the rate of oxidation of a
model substrate peptide. The secreted domain of the S. flexneri
autotransporter protein SigA contains a single pair of cysteine
residues (569CPIPFLC575), which are oxidized to form a disul-
fide in the mature protein. The sequence around the two cys-
teines (Ac-NNNCPIPFLCQKD-NH2) was synthesized and
used as a model substrate peptide. Oxidation of the peptide by
EcDsbA (which is identical in sequence to S. flexneriDsbA) was
monitored by stopped-flow fluorescence. In the course of the
assay, oxidation of the peptide substrate resulted in concomi-
tant reduction of the DsbA enzyme. The intrinsic fluorescence
of the reduced form of EcDsbA is significantly higher than that
of oxidized EcDsbA (46), which enabled the progress of the
reaction to be followed by monitoring the increase in fluores-
cence (Fig. 2). Analysis of the initial rates indicated that the
reactionwas first orderwith respect to peptide andEcDsbAand
proceeded with a second order rate constant of k  1.4 	 106
M1 s1. This is similar to the derived rate constants that have
been reported previously for the reaction of DsbA enzymes
with peptide and protein substrates (32–34) and indicated that
the SigA peptide was efficiently oxidized by EcDsbA.
Structure Determination of the DsbA-Peptide Complex—In
order to characterize substrate binding to DsbA, the crystal
structure of a covalent complex between DsbA and the SigA
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peptide was determined. The covalent complex was stabilized
by replacing the intermolecular disulfide with a more stable
isosteric thioether bond (37) to prevent product release. To
form the complex, a nine-residue peptide encompassing SigA
residues Pro570–Asp578was synthesizedwith a homoserine res-
idue (Hse) in place of the native cysteine (Ac-P1IPFL-Hse-
QKD9-NH2). The hydroxyl of the homoserine was substituted
with bromine to generate the homobromoalanine analogue,
which was reacted with Cys30 of EcDsbA to form a covalent
thioether complex between the peptide and EcDsbA. The isos-
teric thioether bond is more stable than the corresponding
disulfide, and hence the thioether-linked peptide is essentially
bound irreversibly to EcDsbA. The peptide was synthesized
with an acetylated N terminus and an amidated C terminus to
avoid introduction of charges at the termini of the peptide,
which would not be present in the context of the intact SigA
protein.Diffraction quality crystals of the complexwere formed
by soaking the homobromoalanine-SigA-peptide into pre-
formed crystals of reduced EcDsbA. Analysis of the crystals by
SDS-PAGE revealed that the peptide had formed a complex
with 
50% of the DsbA in the crystal, as estimated from the
intensity of the respective bands on SDS-polyacrylamide gels
(Fig. 3a) The structure of the complex was solved by molecular
replacement and refined to a resolution of 1.9Å (Rwork 21.7%,
Rfree 25.2%) (Table 1).
Description of the Structure—Each of the four EcDsbA mol-
ecules within the asymmetric unit adopted a typical DsbA fold
(Fig. 3b), wherein the active site C30PHC33 sequence of EcDsbA
is positioned at the end of helix 1 within the TRX domain of
the protein. The TRX domain contains an inserted -helical
domain. The two domains are linked via a loop between strand
3 of the TRX domain and helix 2 in the helical domain (res-
idues 62–66) and through a loop at the end of the long helix 6
(residues 129–144) (14). The four EcDsbA molecules within
the asymmetric unit were highly similar to one another and
superimposed over the backbone atoms for residues 2–184
with overall rootmean square (r.m.s.) deviation of0.5Å.They
are also similar to previously reported structures of reduced
(Protein Data Bank code 1A2L) and oxidized (Protein Data
Bank code 1FVK) EcDsbA and superimpose over the backbone
atoms for residues 2–184 with overall r.m.s. deviation of 0.5
Å. Of the four EcDsbA molecules in the asymmetric unit, two
(chains C and D) were covalently linked to a SigA peptide
(chains E and F, respectively), whereas the other twoDsbAmol-
ecules (chains A andB)were present in their reduced form. The
covalent complex was formed via a thioether bond between the
C	 in the homoserine of the SigA peptide and S	 in Cys30 of
EcDsbA. Analysis of the structures revealed that binding of the
peptide to the first EcDsbA molecule blocked the equivalent
binding site on the adjacent EcDsbA, accounting for the obser-
FIGURE 2. Oxidation of the SigA peptide by DsbA. Oxidase activity was
determinedbymonitoring theoxidationof SigApeptide substrate. The kinet-
ics of the oxidation reactions were determined using stopped-flow fluores-
cence by monitoring the increase in fluorescence upon reduction of EcDsbA
(1M) in the assay. Progress curves for oxidation of the peptide substrate are
shown at increasing peptide concentrations (0, 2, 5, and 10 M). The rate of
oxidation increases with increasing peptide concentration.
FIGURE 3. Analysis of the DsbA-peptide crystal. a, analysis by SDS-PAGE
(lane ii) revealed that approximately half of the EcDsbA in the crystal had
formed a covalent complex with the peptide. The peptide-DsbA complex
(lane iii) was clearly resolved from free EcDsbA (lane iv) under the conditions
used to run the gel. (Molecular weight markers are shown in lane i.) b, ribbon
diagram of EcDsbA (Protein Data Bank code 3DKS, chain C). Each of the four
molecules in the asymmetric unit adopted a typical DsbA fold comprising a
thioredoxin (blue) and -helical (magenta) domains and the insertion points
(orange). The sulfur atoms of the active site cysteine residues are shown in
yellow CPK representation.
TABLE 1
Data collection and refinement statistics
Values in parenthesis are for the highest resolution shell.
DsbA-peptide complex
Data collection
Space group P212121
Cell dimensions
a, b, c (Å) 85.4, 87.9, 112.6
, , 	 (degrees) 90.0, 90.0, 90.0
Resolution (Å) 1.9
Rmerge 0.109 (0.793)
I/
 (I) 22.1 (2.5)
Completeness (%) 99.8 (99.7)
Redundancy 7.1 (6.6)
Refinement
Resolution (Å) 1.9
No. of reflections 66227
Rwork/Rfree 21.7/25.2
No. of atoms
Protein 5805
Ligand/ion 117
Water 488
B-factors
Protein 24.48
Ligand/ion 37.41
Water 28.84
r.m.s. deviations
Bond lengths (Å) 0.009
Bond angles (degrees) 1.02
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vation that only half of the EcDsbA molecules in the crystal
were present as a complex. The peptides in each of the two
EcDsbA-peptide complexes were highly similar and had an
r.m.s. deviation of 0.21Åover eightC atoms (Fig. 4a). The side
chains of the glutamine at position 7 and lysine at position 8
were mobile in both peptide complexes, as determined by the
lack of prominent electron density in the 2Fo Fcmap (Fig. 4b).
The aspartate at position 9 was disordered and not modeled in
either complex.
DsbA-Peptide Interaction—Analysis of the structure of the
covalent EcDsbA-SigA-peptide complex revealed that the pep-
tide was bound at the interface of the TRX and -helical
domains of DsbA, with contacts being made to both domains.
Details of the DsbA-peptide complex are presented in Fig. 4.
The intermolecular thioether bond displayed an architecture
similar to that of a right-handed disulfide bond (47) with dihe-
dral angles defined by CC30-CC30-S	C30-C	Hse, CC30-S	C30-
C	Hse-CHse, and S	C30-C	Hse-CHse-CHse of 76°/81°, 92°/100°,
and 147°/154° in the two intermolecular complexes of the
asymmetric unit, respectively. This is a conformation similar to
that of the mixed disulfide that is
observed in a TRX-substrate com-
plex (48), indicating that the
thioether provides a suitable isos-
teric replacement of the disulfide.
In addition to the covalent link-
age between the peptide and
EcDsbA, substrate binding was sta-
bilized by hydrogen bonding and
van der Waals interactions (Fig. 4, c
and d), and the binding interface
was almost identical in each com-
plex. Hse6 and Lys8 from SigA
formed hydrogen bonds with Val150
and Arg148 in the cis-proline loop of
EcDsbA, respectively, such that the
loop and substrate peptide were
arranged in an antiparallel fashion,
and a water-mediated hydrogen
bond was formed between the
amide proton of Hse6 and the car-
bonyl oxygen of Val150 (Fig. 4d). In
addition to the hydrogen-bonding
interactions, Phe29 of EcDsbA
packed against Ile2 of the peptide,
whereas Pro31, His32, and Gln35 of
DsbA made contacts to Phe4 of
SigA. Hse6 of the peptide contacted
Met64 of DsbA, and Gln7 and Lys8
made contacts with Phe63, Arg148,
and Gly149. The binding interface in
the DsbA-peptide complex has a
total buried surface area of 760 and
795 Å2 in the two structures, respec-
tively, and a surface complementarity
of 74% as calculated in CCP4 (49).
There were very slight differences in
the packing interactions in the two
DsbA-substrate complexes present in the asymmetric unit of the
unit cell as a result of small changes in the orientation of the side
chain of Ile2 and the mobility of Lys8 (Fig. 4a). In addition, there
were slight differences in the side chain orientations of Phe29 and
Met64 in the two molecules of EcDsbA that were covalently
attached to the peptide. Notwithstanding these small differences,
the 10 residues of EcDsbA that contact the peptide in the complex
could be superimposed over their C atoms with an r.m.s. devia-
tion of 0.12 Å, and the H-bonding interactions were conserved in
the two complexes, indicating that themode of interaction is sim-
ilar. In both cases, residues around the active site (29FCPH32)
together with those in the loop connecting the TRX and -helical
domains (Phe63 andMet64) and residues in the loop preceding the
cis-Pro151 (Arg148,Gly149, andVal150) formed95%of thebinding
surface area.
Characterization of DsbA-Peptide Binding—Given that only
two of the EcDsbA molecules out of the four present in the
asymmetric unit were observed to bind the peptide, there was
concern that the mode of peptide binding was a crystallo-
graphic artifact. In order to address this concern, the binding
FIGURE 4. The substrate binding site of DsbA. a, comparison of the peptide conformation in the two
models of the EcDsbA-peptide complex (Protein Data Bank code 3DKS). Peptide chains E and F are shown
in orange and green stick representation, respectively, and the residues are labeled in orange. The EcDsbA
molecule to which peptide E is covalently attached (chain C) is shown in a schematic diagram. b, omit
(2Fo Fc) electron density map (contoured at 0.8 
) for the peptide (chain E). EcDsbA residues in contact
with the peptide are shown in a blue stick representation. c, polar interactions observed in the complex are
shown as black dotted lines between the interacting residues. Water atoms are shown as red spheres. The
EcDsbA-peptide complex (chains C and E) is shown in the same orientation as above, and EcDsbA residues
are labeled in blue. d, the peptide forms an antiparallel interaction with residues in the cis-proline loop of
EcDsbA. Polar interactions are shown as black dotted lines between the peptide (in orange) and EcDsbA (in
blue).
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location of the SigA peptide was determined by measuring
chemical shift perturbations in 1H-15N HSQC NMR experi-
ments on uniformly 15N-labeled EcDsbA in the absence and
presence of the peptide (Fig. 5). The chemical shifts of reso-
nances in HSQC spectra are exquisitely sensitive to changes in
the environment of the amide groups, and measurement of
chemical shift perturbation is widely used as ameans to identify
the location of ligand binding. A peptide containing homo-
serine in place of cysteine was employed to prevent formation
of a covalent complex and to allow identification of residues
whose resonances were perturbed in the context of a noncova-
lent complex between the peptide and EcDsbA. Analysis of the
spectra revealed that many of the most significant perturba-
tions were observed for residues that formed a continuous sur-
face at the interface between the -helical and TRX domains
(Fig. 5a). The location of the perturbed chemical shifts in the
NMRspectrawas consistentwith themode of binding observed
in the x-ray structure and suggests that the structure represents
a relevantmodel of the biological complex. In contrast, many of
the residues in the hydrophobic
groove that is the binding site for the
periplasmic loop of DsbB were
observed in the 15N HSQC spec-
trumof EcDsbA butwere not signif-
icantly perturbed upon the addition
of the peptide. This suggests that
the SigA peptide binds in a location
that is distinct from the binding site
observed in the crystal structure of
the DsbA-DsbB complex (21). An
interesting feature of NMRdata was
that nopeakwas observed in the 15N
HSQC spectrum for His32 either in
the presence or absence of peptide,
which is consistent with this re-
sidue undergoing conformational
exchange, which has previously
been suggested to be important in
substrate recognition and catalysis
in DsbA enzymes (50).
Comparison of DsbA-Substrate
and DsbA-DsbB Complex—Com-
parison of our structure with the
EcDsbA-EcDsbB complex structure
revealed that the conformation of
EcDsbA was similar in both cases
(Fig. 6). The two EcDsbAmolecules
(Protein Data Bank codes 3DKSD
and 2HI7A) superimposed with an
r.m.s. deviation of 0.59 Å over 179
C atoms. Both the SigA peptide
and the periplasmic loop of EcDsbB
interacted with 148RGV150 in the
cis-proline loop of EcDsbA; how-
ever, the side chains of residues
99PFA101 from the DsbB loop were
buried in the hydrophobic groove,
where they interacted with Pro151,
Pro163, Gln164, Thr168, Met171, and Phe174 of EcDsbA (Fig. 6b).
Thus, although the general mode of interaction with DsbA is
maintained, DsbB appears to make additional interactions
within the hydrophobic groove on the surface of DsbA. These
result in the higher buried surface area observed in the DsbA-
DsbB complex (1340 Å2) (21), which may also account for the
greater specificity of the DsbA-DsbB interaction.
Despite their general similarity, there were some differences
observed between the DsbA molecules in the DsbA-substrate
and DsbA-DsbB complexes. A notable difference was the ori-
entation of the side chain of His32 (Fig. 6c). In the complex with
peptide (Protein Data Bank code 3DKS chain C), H32 adopted a
gauche conformation (1  82°), where its side chain lay
across the face of the hydrophobic groove and blocked access to
the peptide substrate. In the complex with DsbB (Protein Data
Bank code 2HI7), His32 adopted a trans conformation (1 
177°), which allowed access to the hydrophobic groove of
DsbA andwhere its side chainmade van derWaals interactions
with Ala102-Thr103 in the DsbB loop. In the original crystal
FIGURE5.Analysisof EcDsbA-SigApeptide interactionbyNMRspectroscopy.a, EcDsbA residues forwhich
chemical shift perturbations are observed upon the addition of the peptide are colored in magenta on the
crystal structure of the EcDsbA-peptide complex (Protein Data Bank code 3DKS, chain C; the peptide 3DKS,
chain E, is in orange stick format). His32, which is not observed in either HSQC spectrum is colored in cyan.
A continuous surface is formed by residues that form the EcDsbA-peptide interface in the crystal. b, 15N HSQC
spectrum of EcDsbA in the absence (magenta) and presence (cyan) of SigA peptide. The expansion demon-
strates perturbations that are observed for some residues (e.g. Phe29 and Cys33), whereas other residues (e.g.
Gly6 and Asp86) are unaffected.
FIGURE 6. Comparison of the complexes of substrate-DsbA and DsbB-DsbA (Protein Data Bank code
2HI7). a, surface view of the interaction between EcDsbA and SigA peptide. The surface of EcDsbA is shown
with the SigA peptide in an orange stick representation. The position of His32 on the surface is highlighted in
magenta. b, structure of the DsbA-DsbB complex. The surface of EcDsbA is shown with the bound Cys104 loop
in a green stick representation, and the position of His32 is highlighted. c, superposition of the two complexes
reveals that His32 in the complex with SigA peptide (magenta) adopts a different rotameric state compared
with that observed in the complex with DsbB.
The Structure of a DsbA-Peptide Complex
JUNE 26, 2009•VOLUME 284•NUMBER 26 JOURNAL OF BIOLOGICAL CHEMISTRY 17841
 at UQ Library on September 1, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
structure of oxidized EcDsbA (14), there were twomolecules in
the asymmetric unit. These two molecules of oxidized EcDsbA
differed in the orientation of the His32 side chain (in the struc-
ture of oxidized EcDsbA, Protein Data Bank code 1FVK, 1 
160 and 72°, respectively). His32 has been shown to destabilize
the oxidized form of EcDsbA (50), and it has been suggested
previously that movement of this residue may be required to
allow substrate access to the active site (50).
Functional Analysis of DsbA—To determine the role of the
substrate-binding residues of DsbA in defining specificity, we
constructed chimeric proteins comprising the TRX domain of
EcDsbA and the -domain of either NmDsbA1 or NmDsbA2.
These are referred to as EcTDNmDsbA1 and EcTD-
NmDsbA2, respectively. Alignment of the sequences of
EcDsbA, NmDsbA1, and NmDsbA2 (Fig. 7a) revealed that
within the chimeric DsbA enzymes, the loop 148RGV150 in
EcDsbA is replaced by DGT and SGT in EcTDNmDsbA1
and EcTDNmDsbA2, respectively. In addition, residues
Phe63-Met64 of EcDsbA are replaced with WQ and WG in
EcTDNmDsbA1 and EcTD-
NmDsbA2, respectively. In con-
trast, the residues that form the
hydrophobic groove in EcDsbA
are retained in the chimeras.
In order to test the effect of these
mutations, phenotypic analysis was
performed using the dsbA E. coli
strain JCB571 complemented with
EcDsbA, EcTDNmDsbA1, or
EcTDNmDsbA2. First, the sensi-
tivity toDTTof each of the transfor-
mants was determined. Strains of
dsbA E. coli, such as JCB571, are
sensitive to DTT and are unable to
grow on LB agar containing DTT
(Fig. 7, b and c). Transformation of
JCB571 with either of the chimeric
proteins or EcDsbA restored resist-
ance to DTT. This suggested that
each construct was capable of
expressing a functional DsbA
enzyme and that the expressed
DsbA was able to be reoxidized in
the periplasm.
DsbA is also required for the cor-
rect folding and stability of a com-
ponent of the flagellarmotor ofE. coli (FlgI) (51). In the absence
of DsbA, the P-ring component of the flagellar motor is not
formed, which renders dsbA E. coli, such as JCB571, nonmo-
tile. The phenotypic assays revealed that cells transformedwith
either EcDsbA or EcTDNmDsbA2 were motile, whereas
those transformed with EcTDNmDsbA1 were not (Fig. 7, d
and e). This is in contrast to observations with the intact Neis-
serial DsbA enzymes, wherein NmDsbA1 restored motility to
dsbA E. coli, whereas NmDsbA2 did not (29). However, when
the five residues immediately preceding the cis-proline in
EcTDNmDsbA1 (QIDGT) were replaced with the corre-
sponding sequence from EcDsbA (QLRGV), the resulting chi-
meric proteinwas capable of both conferring resistance toDTT
and restoring motility in JCB571 (Table 2). Similarly, replacing
the five residues preceding the cis-proline in EcTDNmDsbA2
(QISGT) with the corresponding sequence from EcDsbA
(QLRGV), the resulting chimeric protein was capable of both
conferring resistance to DTT and restoring motility in JCB571.
Despite the relatively high conservationwithin the sequences
of NmDsbA1 and NmDsbA2, our analysis indicates that
changes introduced by constructing the chimeric proteins are
sufficient to alter the substrate specificity, but they do not
destroy the oxidoreductase activity of the proteins or, appar-
ently their ability to be reoxidized by DsbB. These data suggest
that neither the TRX domain nor the -domain is solely
responsible for conferring substrate specificity and are consist-
ent with the structural details, which reveal that binding takes
place at a surface that encompasses the interface formed
between the two domains. Further, they suggest that substrate
recognition by oxidizedDsbA is different in some respects from
the interaction of reduced DsbA with DsbB, such that changes
FIGURE 7. Phenotypic analysis of chimeric DsbA. a, primary structure of EcDsbA, NmDsbA1, and NmDsbA2.
Residues comprising the thioredoxin domain of EcDsbA are underlined. Residues that make contacts to the
peptide substrate in the crystal structure of the complex are highlighted (*). b–e, phenotypic assays on dsbA
E. coli (JCB571) complemented with different DsbA proteins. b, JCB571 alone (lane 3), JCB571 complemented
with EcDsbA inpTrc99Aas apositive control (lane 4), and JCB571 complementedwith EcTDNmDsbA1 (lane 1)
or EcTDNmDsbA2 (lane 2) were able to growon LB agarwithout DTT, indicating that each of the cell lineswas
viable. c, the same cell lines were tested for growth on LB agar containing 15 mM DTT and 1 mM isopropyl
1-thio--D-galactopyranoside to induce DsbA expression. Each of the cell lines that had been complemented
with theDsbAproteinsgrew,whereas JCB571didnot, indicating that eachconstruct expressedanactiveDsbA.
d, neither JCB571 (zone2) nor JCB571 complementedwith EcTDNmDsbA1 (zone3)wasmotile. In contrast, the
positive control (JCB571 complemented with EcDsbA) (zone 1) was motile. e, both the positive control strain
(zone 1) and JCB571 complemented with EcTDNmDsbA2 (zone 3) were motile, whereas JCB571 (zone 2) was
not.
TABLE 2
Phenotypic analysis of DsbA chimeras
All dsbA geneswere cloned into the low copy vector pHSG576 and assessed for their
ability to restore E. coli dsbAmutant strain JCB571 resistance to DTT and motility.
dsbA DTT resistance Motility
JCB570 (wild type) Yes Yes
JCB571 (dsbA) No No
JCB571 transformed with
EcDsbA Yes Yes
EcTDNMDsbA1 Yes No
EcTDNMDsbA1 (QLRGV) Yes Yes
EcTDNMDsbA2 Yes Yes
EcTDNMDsbA1 (QLRGV) Yes Yes
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in substrate specificity can be achievedwithout apparent loss of
recognition of DsbB.
DISCUSSION
We have determined a high resolution crystal structure of
EcDsbA in complex with a nine-residue peptide derived from
the autotransporter protein SigA of S. flexneri. This structure
revealed that the peptide bound outside the hydrophobic
groove of EcDsbA and contacted residues at the interface
between the TRX and -domains. The complex was stabilized
bymain-chain hydrogen bonds between substrate and residues
in the cis-proline loop of the TRX domain, such that the two
peptide chains were arranged in an antiparallel fashion. The
mode of binding observed in the peptide-DsbA complex dis-
played some similarity to that of a trapped substrate-thiore-
doxin complex (Protein Data Bank entry 2IWT) (48). In both
cases, the complex was stabilized by backbone-to-backbone
hydrogen bonds between the substrate and residues in the cis-
proline loop of the TRX domain, and the loop and peptide were
arranged in an antiparallel fashion. The heavy atoms of the res-
idues of the active site (XCXX(C/S)) and the residues in the loop
immediately preceding the conserved cis-proline residue for
the two complexes (R148GVP in EcDsbA and E88AMP in thi-
oredoxin) superimposed with an r.m.s. deviation value of 0.52
Å. Furthermore, the buried surface areas observed for the
DsbA-substrate complex (760 and 795 Å2) were similar to that
in the thioredoxin-substrate complex (760 Å2) (48). The pres-
ence ofmostlymain-chain interactions aswell as the relatively low
interacting surface in theEcDsbA-SigAcomplex is consistentwith
the broad substrate specificity observedwithmost DsbA enzymes
and the diverse sequences of potential DsbA substrates (31). Cal-
orimetric studies have previously demonstrated that the interac-
tions between DsbA and its substrate proteins are relatively weak
(37), which suggested that small changes in the active site of the
enzymemay be sufficient to alter substrate specificity. This is sup-
ported by previousmutational data, whereby it was demonstrated
that a V150G mutation in EcDsbA was defective in complex for-
mationwith substrate proteins (31).A similarmodeof bindinghas
now been observed for a number of TRX domain-containing
enzymes, including thioredoxin (48, 52, 53), glutaredoxin (54), glu-
tathione transferase (55) as well as themixed disulfide complex of
DsbC-DsbD (56). This mode of interaction is emerging as a gen-
eral feature of substrate recognition in TRX domain-substrate
complexes (48).
However, comparison of the current structure and that of the
EcDsbA-EcDsbB complex, suggests that there are subtle differ-
ences in the manner in which reduced and oxidized EcDsbA
bind their respective substrates. Thus, EcDsbB bound within
the hydrophobic groove of reduced EcDsbA, whereas the SigA
peptide substrate did not. Comparison of the primary structure
of proteins that have been identified as substrate proteins for
EcDsbA (Table 3) reveals that there is no conserved sequence of
hydrophobic residues in the substrate proteins that would pre-
sumably be required for favorable interactionwithin the hydro-
phobic groove. In fact, for those proteins that have been con-
firmed to be substrates of EcDsbA, there is no sequence
conservation in the residues flanking the cysteine (Table 3).
As a consequence of the different location of binding, the
SigA peptide did not contact the conserved cis-Pro151 within
the hydrophobic groove. It has previously been demonstrated
that themutation P151T in EcDsbA results in the accumulation
of DsbA-substrate complexes (31) in the periplasm of E. coli.
This suggests that the P151T mutant is able to both recognize
and form a mixed disulfide with a range of substrate proteins,
but is defective in the step of the reaction pathway where the
complex is resolved with the release of oxidized substrate and
reduced DsbA (Fig. 1). The structure and activity of EcDsbA in
which the cis-proline was mutated to alanine has previously
been reported (57). The activity of EcDsbAP151A, as determined
from its ability to oxidize alkaline phosphatase in a cell-based
assay, was significantly lower than that of wild type EcDsbA.
However, EcDsbB-mediated reoxidation of EcDsbAP151A was
not impaired. In the structure of EcDsbAP151A, the conforma-
tion of the active site residues 30CPHC33 was unchanged,
whereas the positions of residues in the cis-proline loop were
significantly perturbed. These findings suggest that the resi-
dues in the loops surrounding the active site may be of greater
importance in substrate recognition and binding by DsbA than
the hydrophobic groove that is the binding site for DsbB.
Structures have recently been reported for SaDsbA (24) and
NmDsbA3 (23), both of which are oxidoreductase enzymes
that, in contrast to EcDsbA, display a limited substrate reper-
toire aswell asE. coliDsbL,which is thought tohave specificity for
the enzyme arylsulfate sulfotransferase (25). Comparison of each
of these structures with that of EcDsbA reveals significant differ-
ences around the regions identified as the peptide binding surface
in the current study. Notably, SaDsbA andNmDsbA3 have a sim-
ilar TcP sequence in the cis-proline loop. In the case of SaDsbA,
mutation of this sequence to VcP, which is more common in
Gram-negative DsbA enzymes, enhanced the oxidoreductase
activity as measured in an insulin reduction assay (24). Thus, it
TABLE 3
Sequence conservation in DsbA substrates
Forty-five sequences of confirmed substrates of DsbA were compared to assess sequence conservation around the cysteine residue. Analysis of the sequences revealed that
there was no conservation beyond the cysteine residue itself, as determined using Conscore.
Conservative mutations
Hydrophobic, small (AVLI) 17 9 13 8 13 0 15 15 11 5 7
Hydrophobic, aromatic (FYW) 2 8 3 7 3 0 3 4 4 5 2
Acidic (DE) 6 5 6 5 7 0 5 4 2 7 9
Basic (RHK) 7 4 5 6 1 0 5 6 6 8 4
Neutral polar (SMTCNQ) 10 15 9 14 18 45 14 9 13 18 15
Glycine 2 3 6 4 2 0 2 1 5 1 2
Proline 1 1 3 1 1 0 1 6 4 1 5
Percentage of conserved mutations 40.5 36.6 36.1 35.0 42.9 100.0 35.7 39.5 36.1 41.9 40.5
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appears that the sequenceof the cis-proline loopmaybe important
in dictating the substrate binding of DsbA, as has previously been
demonstratedwithotherTRXdomainproteins (27, 28).Although
DsbL retains the VcP sequence in the cis-proline loop, it lacks the
hydrophobic surface features that surround the active site in
EcDsbA and VcDsbA, which supports the notion that these are
important for substrate binding and specificity.
Although the structures of EcDsbA are very similar through-
out the catalytic cycle, differences have been observed in the
relative orientation of theTRXand-helical domains in several
structures of DsbA (17, 18). These are present both for different
DsbA molecules in the same crystal structure, between DsbA
structures solved by different groups, and between the different
forms of DsbA. This has led to the suggestion that dynamics may
play a role in the catalytic activity of DsbA (20). Analysis of the
dynamics in reduced and oxidized forms of VcDsbA has revealed
the presence of interdomain motions in the reduced form of the
protein (18), which result in an opening of the hydrophobic
groove. Redox-dependent conformational changes have previ-
ously been demonstrated to result in the opening of a cavity in the
TRX domain-containing protein ResA (58), which contributes to
substrate specificity. In the case ofDsbA, the conformations of the
different redox states are similar, but changes in the dynamics
appear to allow the reduced form of DsbA to access a more open
conformation, which may facilitate the interaction with the DsbB
loop andenable the formationof amixeddisulfide betweenCys104
of EcDsbB and Cys30 of EcDsbA.
The structure of the EcDsbA-peptide complex presented
herein provides an insight into the specificity observed within
the catalytic cycle of this enzyme. In conjunction with the
description of the structure of a EcDsbA-EcDsbB complex (21)
and differences in the dynamics of the different redox states of
the VcDsbA enzyme (18), a clearer picture is beginning to
emerge of the factors regulating the catalytic cycle of DsbA.
Thus, oxidized DsbA appears to bind its substrates through a
mechanism that is common to many TRX family oxidoreduc-
tases via the formation of backbone hydrogen bonds to a loop
immediately prior to the conserved cis-proline residue of the
TRX fold. Subtle changes in the composition of this loop and
the residues that surround it appear to influence substrate spec-
ificity. The relatively higher specificity of reduced DsbA for
DsbB results from additional interactions of DsbB within the
hydrophobic groove on the surface of DsbA, which may
becomemore accessible as a result of interdomainmotions that
are present in the reduced DsbA.
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S2 
Supplementary Table 1: FABP sequence alignments 
 
 
(A) Sequence alignment of the primary structures of rat FABP proteins. (* = conservative residue, : 
= conserved substitution, . = semi-conserved substitution. Alignment conducted using Cluster W 
2.0)  (B) Comparison of human and rat L-FABP. Sequence alignment of the primary structures of 
L-FABP. 
S3 
Supplementary Table 2. Binding site occupancy 
Percentage occupancy at each site for rL-FABP (300 M) at a 3-fold molar excess of each of the 
fibrate drugs used in the current study. 
 
 % Occupancy 
Ligand 1st Site 2nd Site
Fenofibrate 100 100 
Gemfibrozil 100 79 
Bezafibrate N/A 93 
Ciprofibrate 100 85 
Clofibrate 99 N/A 
Fenofibric Acid 100 96 
S4 
Supplementary Table 3. Temperature dependence of binding affinities 
Binding affinity constants of fenofibric acid, fenofibrate and clofibrate for L-FABP measured from 
steady state fluoresecence at different temperatures, used for van’t Hoff determination of 
thermodynamic parameters. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Kd1 High affinity site; Kd2 low affinity site; ND, Not detected; Affinity values are the mean  the 
standard deviation of three independent measurements. 
 
 
 
 
 
 
 
 
 
 
Temperature 
(C) 
Fenofibric 
Acid (M) 
Fenofibrate 
(M) 
Clofibrate 
(M) 
5 Kd1=0.094 ± 0.01 
Kd2=18 ± 2.2 
Kd1=0.018 ± 0.0020 
Kd2=0.13 ± 0.020 
Kd1=6.0 ± 2.9 
10 Kd1=0.10 ± 0.02 
Kd2=19 ± 1.9 
Kd1=0.023 ± 0.0010 
Kd2=0.15 ± 0.010 
Kd1=6.7 ± 1.7 
15 Kd1=0.16 ± 0.04 
Kd2=20 ± 1.8 
Kd1=0.024 ± 0.0020 
Kd2=0.16 ± 0.020 
Kd1=7.3 ± 1.4 
20 Kd1=0.22 ± 0.030 
Kd2=23 ± 2.0 
Kd1=0.027 ± 0.0030 
Kd2=0.20 ± 0.020 
Kd1=7.8 ± 2.5 
25 Kd1=0.34 ± 0.020 
Kd2=24.0 ± 2.1 
Kd1=0.032 ± 0.0040 
Kd2=0.25 ± 0.020 
Kd1=8.9 ± 2.8 
30 Kd1=0.36 ± 0.040 
Kd2=27 ± 2.5 
Kd1=0.041 ± 0.0040 
Kd2=0.27 ± 0.040 
Kd1=9.6 ± 1.9 
37 Kd1=0.42 ± 0.030 
Kd2=28 ± 3.0 
Kd1=0.062 ± 0.006 
Kd2=0.32 ± 0.030 
Kd1=11 ± 3.4 
42 Kd1=ND 
Kd2=29 ± 3.5 
Kd1=ND 
Kd2=0.36 ± 0.040 
Kd1=12 ± 3.0 
S5 
Supplementary Figure 1. 1H-15N HSQC data for rL-FABP 
 
 
 
 
A portion of the HSQC spectrum of apo rL-FABP is shown in red and labeled with the assignment 
of each peak. (A) The HSQC spectrum of rL-FABP in the presence of three molar equivalents of 
clofibrate (green) is overlaid onto the spectrum of apo rL-FABP. The presence of clofibrate results 
in significant perturbation of several of the peaks. (B) The HSQC spectrum of rL-FABP in the 
presence of three molar equivalents of fenofibric acid (blue) is overlaid onto the spectrum of apo 
rL-FABP. Some peaks are perturbed upon addition of fenofibric acid, others are perturbed and 
demonstrate significant broadening (e.g. G76), whilst some are broadened beyond the limit of 
detection in the experiment (e.g. G32, G37, T75, T108).  
S6 
Supplementary Figure 2. Docking of fenofibric acid methyl ester 
 
 
 
 
 
 
 
 
 
 
 
A. A comparison of the docking clusters of fenofibrate (light blue carbon atoms) binding at the high 
affinity site of rL-FABP with those obtained for the methyl ester of fenofibric acid (magenta carbon 
atoms), which was docked using the same protocol. The poses for the two compounds are similar, 
suggesting that for these two compounds, the nature of the small aliphatic group in of the ester is 
not a dominating factor in driving the binding orientation. B. 90 degree rotation of the same. 
 
S7 
Supplementary Figure 3. Docking clusters for fenofibrate 
 
 
 
The seven docking clusters of fenofibrate along with their scores based on correlation with the 
CSPs observed in the NMR data. 
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